LPTX Leap Therapeutics, Inc. Net earnings per share growth this year

LPTX (leaptx.com) - company brandmark

Leap Therapeutics, Inc. (LPTX) is facing a liquidity shortage due to costly trials, resulting in negative cash flow. Analyzing the annual earnings per share trend on GURU.Markets, we observe that the value of 0.00 aligns with the current metric. The company focuses on gastrointestinal therapies, leveraging regulatory priority statuses and global antibody development partnerships to mitigate financial risks.

Leap Therapeutics (LPTX): Net earnings per share growth this year from 07/04/2022 to 11/13/2025

Analytical breakdowns and data insights for company leaptx.com (LPTX)

- current quotes and average value forecast:
Summary company analysis:LPTX (Leap Therapeutics)
Brand item of Leap Therapeutics, Inc.

The strategic alliance of Leap Therapeutics, Inc. (LPTX) with Merck and BeiGene to develop DKN-01 establishes the foundation for a commercial breakthrough in cancer immunotherapy. This percentage deviation of EPS from the previous year's level measures the dynamics of net profit per share, revealing the pace of business scaling. The positive trend confirms the effectiveness of clinical synergies and the growth of capitalization. Investors should view this indicator as a marker of the transition from the cost-intensive phase to profitability. Steady growth of this metric ensures the stability of market quotes.

Key competitors

IBRX - Expected net earnings per share growth this year|Earnings per share growth in current year immunocore.com|Net earnings per share growth this year januxrx.com (JANX)|Earnings per share growth in current year Arcus Biosciences Inc (RCUS)|Net earnings per share growth this year Zymeworks Corp ZYME|Tango Therapeutics Inc - Net earnings per share growth this year|Earnings growth in current year Iovance Corp IOVA|IMTX - Earnings per share growth in current year|XNCR (xencor.com) - Earnings per share growth this year|Compass Therapeutics Corp (CMPX) - Earnings per share growth in current year|Earnings per share growth rate in current year Replimune Corp (REPL)|Net earnings per share growth this year LYEL|IPHA - Net earnings per share change in current year|Net earnings per share growth this year PYXS (Pyxis Oncology, Inc.)|Net earnings per one share growth for the current year CGEN|Earnings growth in current year IOBT (IO Biotech)|Earnings per share increase in current year STRO|minktherapeutics.com - Earnings growth in current year|Earnings per share growth rate in current year Werewolf Therapeutics, Inc.|Immix (IMMX) - Earnings per share growth in current year|ALX Oncology Holdings - Earnings per share increase in current year|Earnings per share growth in current year Cue Biopharma|Earnings growth in current year pdsbiotech.com|Earnings per share growth in current year sonnetbio.com (SONN)|MAIA: Earnings per share trend in current year|Liminatus Pharma Inc. - Net earnings per share growth this year|LAVA Therapeutics N.V. (LVTX) - Earnings per share growth rate in current year|NXTC - Earnings per share growth in current year|Expected net earnings per share growth this year Intensity Therapeutics, Inc. INTS|SNSE: Earnings growth in current year|Synthetic Biologics - Earnings per share increase in current year|GRTS (Gritstone bio) - Earnings growth in current year|KA (Kineta, Inc.) - Net earnings per one share growth for the current year|Earnings growth in current year NEXI|Turnstone Biologics Corp - Earnings per share growth this year|Earnings growth in current year VCNX (Vaccinex Inc)|Harpoon Therapeutics Corp (HARP) - Earnings per share growth rate in current year